Stellar outlines strategy at Cowen conference; gets Chinese patent
March 8, 2010 by stephenkilmer · Leave a Comment
Upcoming milestones for Stellar Pharmaceuticals (OTCBB:SLXCF) provide for near-and mid-term investment triggers, President and CEO, Peter Riehl, said in a presentation at the SG Cowen healthcare conference in Boston. Stellar, which is only one of three Canadian companies presenting at the Cowen conference, is aggressively expanding its global out-licensing programs for its two lead products [...]
Listen to BioTuesdays 
